In animal research, Noopept may increase alpha waves in the brain similarly to the function of Piracetam; however, Noopept also increases beta waves and decreases delta waves.  In animals, Noopept is believed to work with acetylcholine and neurotrophin in the brain, although it is not entirely understood
 
N-Phenylacetyl-L-prolylglycine ethyl ester is promoted as a nootropic and is a prodrug of cycloprolylglycine. 
Other names include the brand name Noopept (Russian: Ноопепт), developmental code GVS-111; proposed INN omberacetam. 

Its synthesis was first reported in 1996.